Prelude Capital Management’s CryoPort CYRX Stock Holding History

Prelude Capital Management’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$161K	Sell	10,252 -2,837	-22%	-$36.4K	0.01%	1025
2026 Q1	$108K	Sell	13,089 -10,006	-43%	-$90.4K	0.01%	1041
2025 Q4	$222K	Buy	+23,095	New	+$218K	0.02%	992
2025 Q1	–	Sell	-12,847	Closed	-$100K	–	1260
2024 Q4	$100K	Buy	+12,847	New	+$95.8K	0.01%	1095
2022 Q1	–	Sell	-15,949	Closed	-$944K	–	1908
2021 Q4	$944K	Sell	15,949 -4,841	-23%	-$335K	0.02%	644
2021 Q3	$1.38M	Buy	20,790 +85	+0.4%	+$5.24K	0.04%	435
2021 Q2	$1.31M	Sell	20,705 -1,233	-6%	-$69.4K	0.04%	469
2021 Q1	$1.14M	Buy	+21,938	New	+$1.33M	0.03%	547

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Prelude Capital Management's CYRX Position: Q2 2026 in Review

Prelude Capital Management reduced its CryoPort (CYRX) stake by 22% in Q2 2026, selling an estimated $36.4K and leaving 10,252 shares worth $161K. The position accounts for 0.01% of the portfolio, ranked #1025.

Prelude Capital Management first reported a position in CYRX in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.38M in Q3 2021. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Prelude Capital Management held 10,252 shares of CryoPort worth $161K as of Q2 2026.
Prelude Capital Management sold 2,837 CryoPort shares in Q2 2026, an estimated $36.4K.
CryoPort made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1025 holding.
Prelude Capital Management first reported a position in CryoPort in Q1 2021 and has held it in 8 quarters since.
Prelude Capital Management's CryoPort position peaked at $1.38M in Q3 2021.
184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.